Table 1.
Demographic and baseline characteristics of participants with or without cardiovascular deaths
| No cardiovascular death (n = 12,290) | Cardiovascular death (n = 150) | P value | |
|---|---|---|---|
| Age (years) | 46.0 (31.0, 62.0) | 75.0 (65.3, 80.0) | < 0.001 |
| Age group | |||
| < 65 years | 9779 (79.6%) | 33 (22.0%) | < 0.001 |
| ≥ 65 years | 2511 (20.4%) | 117 (78.0%) | |
| Gender | |||
| Male | 5936 (48.3%) | 98 (65.3%) | < 0.001 |
| Female | 6354 (51.7%) | 52 (34.7%) | |
| Race | |||
| Mexican American | 2081 (16.9%) | 15 (10.0%) | < 0.001 |
| Non-Hispanic white | 5299 (43.1%) | 93 (62.0%) | |
| Non-Hispanic black | 2596 (21.1%) | 29 (19.3%) | |
| Other races | 2314 (18.8%) | 13 (8.7%) | |
| Drinking | 8774 (71.4%) | 107 (71.3%) | 0.988 |
| Smoking | 5402 (44.0%) | 89 (59.3%) | < 0.001 |
| Hypertension | 4586 (37.3%) | 110 (73.3%) | < 0.001 |
| Diabetes | 1879 (15.3%) | 48 (32.0%) | < 0.001 |
| CAD | 1288 (10.5%) | 35 (23.3%) | < 0.001 |
| Stroke | 681 (5.5%) | 19 (12.5%) | 0.011 |
| Lipid-lowering drugs | 2588 (21.1%) | 67 (44.7%) | < 0.001 |
| TC (mmol/L) | 4.86 (4.19, 5.59) | 4.82 (4.09, 5.61) | 0.563 |
| TG (mmol/L) | 1.15 (0.81, 1.69) | 1.33 (1.02, 2.04) | < 0.001 |
| HDL-C (mmol/L) | 1.34 (1.11, 1.63) | 1.27 (1.09, 1.58) | 0.121 |
| LDL-C (mmol/L) | 2.85 (2.28, 3.50) | 2.76 (2.07, 3.47) | 0.191 |
| ApoB (mg/dL) | 89.0 (73.0, 107.0) | 96.0 (75.0, 113.5) | 0.049 |
| LAR | 1.25 (1.12, 1.35) | 1.13 (1.01, 1.24) | < 0.001 |
Data were presented as median (IQR) or N (%). CAD Coronary artery disease, TC Total cholesterol, TG Triglycerides, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, ApoB Apolipoprotein B, LAR The LDL cholesterol concentration to total apolipoprotein B concentration ratio